⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27254599 | 0.84 | — | — | |
| SCHEMBL2742876 | 0.84 | — | — | |
| SCHEMBL16543649 | 0.81 | — | — | |
| SCHEMBL25797559 | 0.79 | — | — | |
| SCHEMBL18233152 | 0.76 | — | — | |
| SCHEMBL25797561 | 0.74 | ACHE (0.37) | — | |
| SCHEMBL18119006 | 0.74 | — | — | |
| SCHEMBL13287083 | 0.73 | — | — | |
| SCHEMBL13123077 | 0.73 | — | — | |
| SCHEMBL15499095 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10238753-B2 | Antisense conjugates for decreasing expression of DMPK | VALERION THERAPEUTICS, LLC (US) | 2019-03-26 | — | — | US | disclosed |
| US-20180021449-A1 | ANTISENSE CONJUGATES FOR DECREASING EXPRESSION OF DMPK | VALERION THERAPEUTICS, LLC | 2018-01-25 | — | — | US | disclosed |